Effect of low molecular weight heparin on pancreatic micro-circulation in severe acute pancreatitis in a rodent model

Chinese Medical Journal

Volumn 120, Issue 24, 2007, Pages 2260-2263

  Qiu, Fu ^a   Lü, Xin Sheng ^a   Huang, Yu Kun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Acute pancreatitis; Low molecular weight heparin; Microcirculation

Indexed keywords

AMYLASE; ENDOTHELIN 1; LOW MOLECULAR WEIGHT HEPARIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; ELECTRON MICROSCOPY; MICROCIRCULATION; MICROTHROMBUS; NONHUMAN; PANCREAS BLOOD FLOW; PROTEIN BLOOD LEVEL; RAT; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TISSUE STRUCTURE;

EID: 38349165591     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200712020-00020     Document Type: Article

References (20)

1. Renzulli P, Jakob SM, Tauber M, Candinas D, Gloor B. Severe acute pancreatitis: case-oriented discussion of interdisciplinary management. Pancreatology 2005; 5: 145-156.
2. Schneider L, Pietschmann M, Hartwig W, Marcos SS, Hackert T, Gebhard MM, et al. Inosine reduces microcirculatory disturbance and inflammatory organ damage in experimental acute pancreatitis in rats. Am J Surg 2006; 191: 510-514.
3. Qiu F, Lu XS. Severe acute pancreatitis and multiple organ dysfunction syndrome. Foreign Med Sci (Pathophysiol Clin Medi) (Chin) 2004; 6: 85-88.
4. Fan QQ, Lu XS, Fan LQ, Qiu F. Experimental study of low molecular weight hepatin therapy for prevention of acute pancreatitis after ERCP. Chin J Gen Surg (Chin) 2002; 11: 175-177.
5. Qiu F, Lu XS, Li YX. Low molecular weight heparin therapy for severe acute pancreatitis:a prospective clinical study. Chin J Gen Surg (Chin) 2004; 13: 721-726.
6. Qiu F, Lu XS, Huang YK. Experimental study of low molecular weight heparin therapy for kidney injury in severe acute pancreatitis. J Chin Physician (Chin) 2005; 7: 602-604.
7. Qiu F, Lu XS, Li YX, Li JQ, Fan QQ, Zhou RG. Prospective clinical study on preventing effects of low molecular weight heparin on pancreatic encephalopathy in severe acute pancreatitis. Chin J Hepatob Surg (Chin) 2006; 12: 622-624.
8. Lu XS, Qiu F, Li JQ, Fan QQ, Zhou RG, Ai YH, et al. Low molecular weight heparin in the treatment of severe acute pancreatitis: a multiple center prospective clinical study. Chin J Gen Surg (Chin) 2006; 21: 500-503.
9. Fan QQ, Lu XS, Qiu F, Fan LQ, Zhan YQ. Experimental study of low molecular weight heparin in the treatment of severe acute pancreatitis. Chin J Gen Surg (Chin) 2004; 13: 412-414.
10. Li JQ, Zhang KC, Lu XS, Xiao CQ, Xia HZ. Low molecular weight heparin for acute hemorrhagic necrotizing pancreatitis in rabbits. Chin J Gen Surg (Chin) 2000; 9: 234-236.
11. Lu XS, Zhang KC, Li JQ. Effects of low molecular weight heparin in the treatment of the complications of severe acute pancreatitis. J Hepatopancreatob Surg (Chin) 2002; 14: 76-77.
12. Pereda J, Sabater L, Cassinello N, Gomez-Cambronero L, Closa D, Folch-Puy E, et al. Effect of simultaneous inhibition of TNF-alpha production and xanthine oxidase in experimental acute pancreatitis: the role of mitogen activated protein kinases. Ann Surg 2004; 240: 108-116.
13. Leveau P, Wang X, Sun Z, Borjesson A, Andersson E, Andersson R. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant. Biochem Pharmacol 2005; 69: 1325-1331.
14. Hershkoviz R, Bruck R, Aeed H, Shirin H, Halpern Z. Treatment of concanavalin A-induced hepatitis in mice with low molecular weight heparin. J Hepatol 1999; 31: 834-840.
15. Norman JG, Fink GW, Denham W, Yang J, Carter G, Sexton C, et al. Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction. Dig Dis Sci 1997; 42: 1783-1788.
16. Hughes CB, Gaber LW, Mohey el-Din AB, Grewal HP, Kotb M, Mann L, et al. Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis. Am Surg 1996; 62: 8-13.
17. Darien BJ, Fareed J, Centgraf KS, Hart AP, MacWilliams PS, Clayton MK, et al. Low molecular weight heparin prevents the pulmonary hemodynamic and pathomorphologic effects of endotoxin in a porcine acute lung injury model. Shock 1998; 9: 274-281.
18. Plusczyk T, Bersal B, Westermann S, Menger M, Feifel G. ET-1 induces pancreatitis-like microvascular deterioration and acinar cell injury. J Surg Res 1999; 85: 301-310.
19. Eibl G, Buhr HJ, Foitzik T. Therapy of microcirculatory disorders in severe acute pancreatitis: what mediators should we block? Intensive Care Med 2002; 28: 139-146.
20. Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119 (1 Suppl): 64S-94S.